Cont… Results in folic acid deficiency and thereby inhibition of bacterial growth as well as injury to the bacterial cell. Sulfonamides are bacteriostatic not bactericidal.
RESISTANCE
PHARMACOKINETICS
THERAPEUTIC USES
Cont…
ADVERSE DRUG REACTION
Cont…
Stevens–Johnson syndrome
Trachoma of eye Exfoliative dermatitis
Contraindications
COTRIMOXAZOLE
INTRODUCTION
Trimethoprim
ANTI BACTERIAL SPECTRUM
THERAPEUTIC USES
ADVERSE DRUG REACTION
QUINOLONES
QUINOLONES
Fluoroquinolones
Fluoroquinolones .
Generation Drug Names Spectrum 1st Nalidixic acid Cinoxacin Gram- but not Pseudomonas species 2nd Norfloxacin Ciprofloxacin Ofloxacin Gram- (including Pseudomonas species), some Gram+ (S. aureus) and some atypicals 3rd Levofloxacin Sparfloxacin Moxifloxacin Gemifloxacin Gatifloxacin Same as 2 nd generation with extended Gram+ and atypical coverage 4th Trovafloxacin Same as 3 rd generation with broad anaerobic coverage *withdrawn from the market in 1999
NORFLOXACIN (NORFLOX) It is less potent than ciprofloxacin due to less bioavailability Is primarily used for UTI & bacterial diarrhoea It is not recommended for respiratory & systemic infections, particularly where gram-positive cocci are involved Oral Availability % - 30-40% T1/2 (hours) - 3-4 Oral dose - 400 mg twice daily
OFLOXACIN (TARIVID) Effective against gram-negative organism More active than ciprofloxacin against gram-positive organism ,chlamydia,mycoplasma. It is used in Tuberculosis ,leprosy, Atypical pneumonia & chlamydial infections. Oral Availability % - About 95% Indication - Like ciprofloxacin T 1/2 (hours) - 5-7 Oral dose - 200-400 mg. once daily;
LEVOFLOXACIN (TAVANIC) Increased activity against streptococcus pneumoniae,effective against gram – ve bacteria & anaerobes. Oral Availability % - > 90% Indication - community acquired pneumonias,chronic bronchitis,skin,soft tissue & UTI T 1/2 (hours) - 6-8 Oral dose - 7-14 days